Kendra Adams
Director of Finance/CFO presso C4 THERAPEUTICS, INC.
Patrimonio netto: 670 259 $ in data 31/03/2024
Profilo
Kendra R.
Adams is currently the Chief Financial Officer & Treasurer at C4 Therapeutics, Inc. She previously worked as the Director-Investor Relations at ARIAD Pharmaceuticals, Inc. and as the VP-External Communications & Investor Relations at Agios Pharmaceuticals, Inc. Ms. Adams completed her undergraduate degree at Hamilton College (New York).
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
0.12% | 07/03/2024 | 82 039 ( 0.12% ) | 670 259 $ | 31/03/2024 |
Posizioni attive di Kendra Adams
| Società | Posizione | Inizio |
|---|---|---|
| C4 THERAPEUTICS, INC. | Director of Finance/CFO | 18/09/2023 |
Precedenti posizioni note di Kendra Adams
| Società | Posizione | Fine |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| ARIAD PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Formazione di Kendra Adams
| Hamilton College (New York) | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Kendra Adams
